DOI: 10.1001/jamaoncol.2026.2843 ISSN: 2374-2437

Recent Food and Drug Administration Decisions and the Future of the Development of Cancer Drugs in the US

Gilberto Lopes

This Viewpoint discusses recent US Food and Drug Administration (FDA) decisions regarding oncology drug trials for refractory melanoma and their potential negative impacts on the US regulatory environment.

More from our Archive